Join Vicki Bebeau, renowned clinical strategist and industry expert, to talk about what to expect and how to prepare. Jim Harmon, US reimbursement specialist, will join the panel, to address the key topic of US reimbursement for category A or B IDE trials.

With COVID 19, medical device companies are facing increasing complexity to conduct their clinical trials in the US.